Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
NAGLUN-acetyl-alpha-glucosaminidase     | 17q21.2 | * Charcot-Marie-Tooth neuropathy Type 2V - CMT2V (14.64)
|
NARS1Asparaginyl-tRNA Synthetase 1     | 18q21.31 | * Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities - NEDMILG (14.136, 14.79) * Charcot-Marie-Tooth disease, axonal, related to NARS1 - CMT2 (14.136, 14.79)
|
NDRG1N-myc downstream regulated gene 1     | 8q24.3 | * Charcot-Marie-Tooth disease, type 4D - CMT4D (14.27)
* Neuropathy, hereditary motor and sensory, lom type - HMSNL (14.27)
* Hereditary motor and sensory neuropathy – Lom (with deafness) - HMNSL (14.27)
|
NDUFAF1NADH-ubiquinone oxidoreductase 1 alpha subcomplex(M)     | 15q15.1 | * patient with HCM and isolated respiratory complex I deficiency - (10.31) * Hypertrophic mitochondrial cardiomyopathy related to NDUFAF1 - (10.31)
* Mitochondrial complex 1 deficiency, nuclear type 11 - MC1DN11 (10.31)
|
| 2q22 | * Distal myopathy with nebulin defect - (3.5, 4.17, 4.18)
* Nemaline myopathy 2, autosomal recessive - NEM2 (3.5, 4.17, 4.18)
|
NEFHNeurofilament, heavy polypeptide     | 22q12.2 | * Susceptibility to amyotrophic lateral sclerosis related to NEFH - ALSDC (12.82, 14.68)
* Charcot-Marie-Tooth disease, axonal, type 2CC - CMT2CC (12.82, 14.68)
|
NEFLNeurofilament, light polypeptide 68kDa     | 8p21 | * Charcot-Marie-Tooth disease, type 1F - CMT1F (14.7, 14.20, 14.52)
* Charcot-Marie-Tooth disease, type 2E - CMT2E (14.7, 14.20, 14.52)
* Charcot-Marie-Tooth disease, dominant intermediate G - CMTD1G (14.7, 14.20, 14.52)
|
NEK1Never in motosis gene A-related kinase 1     | 4q33 | * Amyotrophic lateral sclerosis, susceptibility to, 24 - ALS24 (12.77)
|
NEK9Never in mitosis gene A-related kinase 9     | 14q24.3 | * Lethal Congenital Contracture Syndrome 10 - LCCS10 (12.99)
|
NEXNNexilin(F-actin binding protein)      | 1p32-p31 | * Hypertrophic cardiomyopathy related to nexilin - (10.21, 10.66) * Cardiomyopathy, familial hypertrophic 20 - CMH20 (10.21, 10.66)
* Cardiomyopathy, dilated, 1CC - CMD1CC (10.21, 10.66)
|
NFU1NFU1 iron-sulfur cluster scaffold     | 2p13.3 | * Spastic paraplegia 93, autosomal recessive - SPG93 (15.82)
|
NGFNerve growth factor (beta polypeptide)     | 1p13.1 | * neuropathy, hereditary sensory and autonomic type v - HSAN5 (14.110)
|
NIPA1Non imprinted gene in Prader-Willi/Angelman syndrome chromosome region 1     | 15q11.2 | * Spastic paraplegia 6 uncomplicated,autosomal dominant,Strumpell-Lorrain type - SPG6 (15.3)
|
| 10q26.3 | * Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy - SPAX8 (15.97)
|
NMNAT2Nicotinamide nucleoside adenyltransferase 2     | 1q25.3 | * Polyneuropathy with erythromelalgia - (14.124)
|
NOP56NOP56 ribonucleoprotein     | 20p13 | * Spinocerebellar ataxia 31 - SCA36 (13.32)
|
NOTCH2NLCNotch2 N-terminal-like protein    | 1q21.2 | * Neuronal intranuclear inclusion diseases - NIID (5.25, 14.134, 14.77) * Oculopharyngodistal myopathy - (5.25, 14.134, 14.77) * Charcot-Marie-Tooth disease, axonal, related to NOTCH2NLC - CMT2 (5.25, 14.134, 14.77)
|
NPPANatriuretic peptide precursor A     | 1p36.22 | * atrial fibrillation, familial, 6 - ATFB6 (10.163)
|
NPTX1Neuronal pentraxin 1     | 17q25.3 | * Spinocerebellar ataxia 50 - SCA50 (13.46)
|
NSUN3NOP2/SUN RNA Methyltransferase Family Member 3    | 3q11.2 | * Combined oxidative phosphorylation deficiency - COXPD48 (17.46)
|
NT5C25'-nucleotidase, cytosolic II     | 10q24-q32 | * Spastic paraplegia 45, autosomal recessive - SPG45 (15.45)
|
NTRK1neurotrophic receptor tyrosine kinase 1     | 1biq23.1 | * Hereditary sensory and autonomic neuropathy type IV - HSAN4 (14.109)
|
NUP155Nucleoporin 155 kDa     | 5p13.2 | * Atrial fibrillation, 15 - ATFB15 (10.172)
|
| 17p13.2 | * Fetal akinesia deformation sequence 4 - FADS4 (17.31)
|
NUTM2B-AS1NUTM2B antisens RNA 1    | 10q22.3 | * Oculopharyngeal myopathy with leukoencephalopathy 1 - OPML1 (5.28)
|